Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NAC for HAAF in Type 1 Diabetes
NCT02206152Phase 2Completed
- Sponsor
- University of Minnesota
- Start
- Feb 2015
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of acetylcysteine in hypoglycemia-associated autonomic failure (HAAF), sponsored by University of Minnesota. Started Feb 2015; status: completed.
02
Drugs
acetylcysteine
03
Conditions
hypoglycemia-associated autonomic failure (HAAF)
Beyond the preview
Go deeper on NCT02206152.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02206152.